Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statements (Forms S-3 and S-3/A No. 333-212439) pertaining to the offering and resale by selling stockholders, including their transferees, pledges or donees, of up to 13,102,084 shares of the common stock of Pieris Pharmaceuticals, Inc., |
| (2) | Registration Statements (Forms S-3 and S-3/A No. 333-211844) pertaining to the registration of up to $100,000,000 of common stock or preferred stock upon conversion of or exchange for debt securities; common stock upon conversion of or exchange for the preferred stock; common stock, preferred stock or debt securities upon the exercise of warrants, rights units or performance of purchase contracts; or any combination of these securities upon the performance of purchase contracts, |
| (3) | Registration Statement (Form S-8 No. 333-213771) pertaining to the Pieris Pharmaceuticals, Inc. 2016 Employee, Director and Consultant Equity Incentive Plan, |
| (4) | Registration Statement (Form S-8 No. 333-209308) pertaining to the Pieris Pharmaceuticals, Inc. 2014 Employee, Director and Consultant Equity Incentive Plan and Inducement Stock Option Award for Louis Matis, M.D., |
| (5) | Registration Statement (Form S-8 No. 333-204487) pertaining to the Pieris Pharmaceuticals, Inc. 2014 Employee, Director and Consultant Equity Incentive Plan; |
| (6) | Registration Statement (Post-Effective Amendment to Form S-1 filed on Form S-3 No 333.202123) and related prospectus of Pieris Pharmaceuticals, Inc. for the registration of 15,250,634 shares of its common stock; |
of our report dated March 23, 2016, with respect to the consolidated financial statements of Pieris Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Pieris Pharmaceuticals, Inc. for the year ended December 31, 2015.
| /s/ Dr. Napolitano | /s/ Christ | |
| Wirtschaftsprüfer | Wirtschaftsprüfer | |
| [German Public Auditor] | [German Public Auditor] |
Ernst & Young GmbH
Wirtschaftsprüfungsgesellschaft
Munich, Germany
March 29, 2017